🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.

Some professionals stated the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the platform has taken down violative content and banned related keywords and search suggestions. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also found communities with up to nine thousand members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for mixing or administering at home.

After moments of entering one group, a vendor posted WhatsApp details, where most transactions occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about body mass, health issues or past usage.

Item Details and Costs

Inside these communities, posts display black plastic parcels with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When asked how long a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram said it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to possibly serious medical dangers”.